ConductScience.org, home

Paper19720809

Development and first validation of the COPD Assessment Test.

Jones PW and 5 others. Eur Respir J, 2009. Cited by 2,534 papers, by iCite.

Cite this record

ConductScience Library. Development and first validation of the COPD Assessment Test. Papers, record 19720809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19720809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development and first validation of the COPD Assessment Test.
PubMed
Journal
Eur Respir J
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Validation Study
PubMed
Citations, by iCite
2,534
iCite
Relative citation ratio, by iCite
90.9
iCite
Revised in PubMed
2022-04-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones PWP W
2Harding GG
3Berry PP
4Wiklund II
5Chen WHW-H
6Kline Leidy NN

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Health Status IndicatorsMajor topic
Pulmonary Disease, Chronic ObstructiveMajor topic
Surveys and QuestionnairesMajor topic
Adult
Aged
Aged, 80 and over
Europe
Female
Humans
Male
Middle Aged
Predictive Value of Tests
Psychometrics
Quality of Life
Reproducibility of Results
United States

Source PubMed

Download CSV of topics

Trials29

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01880177Developing a COPD Case Finding Methodology for Primary CareBackgroundClinicalTrials.gov
NCT02706600Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPDBackgroundClinicalTrials.gov
NCT02706613Comparing Online Pulmonary Rehabilitation 'myPR' Versus Conventional Pulmonary Rehabilitation for Patients With COPDResultsClinicalTrials.gov
NCT02838108The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD CohortBackgroundClinicalTrials.gov
NCT02973945High Flow Nasal Cannula and Aerobic Capacity TrainingResultsClinicalTrials.gov
NCT03084796A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary DiseaseBackgroundClinicalTrials.gov
NCT03251781Minimal Important Difference for the Glittre-ADL Test and London Chest Activity of Daily Living ScaleBackgroundClinicalTrials.gov
NCT03322787Effect of Exercise Training Under HFO Device on Endurance Tolerance in Patients With COPD and CRF: a Randomized Controlled Study.BackgroundClinicalTrials.gov
NCT03323190An Educational Intervention to Improve Disease Management Knowledge of Hospitalized Patients With COPDBackgroundClinicalTrials.gov
NCT03355677A Study Into Airways Disease Case Finding and ManagementBackgroundClinicalTrials.gov
NCT03692793Pulmonary Rehabilitation in Functional Outcomes and Its Relationship With Morbidity and Mortality in Patients With COPDBackgroundClinicalTrials.gov
NCT04201548Different Modalities of Exercise Training in COPD With Chronic Respiratory Failure (CRF)BackgroundClinicalTrials.gov
NCT04320342A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDBackgroundClinicalTrials.gov
NCT04482634Tele-rehabilitation Versus Home Exercise Program in COVID-19ResultsClinicalTrials.gov
NCT04584671Lung Structure-Function In Survivors of Mild and Severe COVID-19 InfectionBackgroundClinicalTrials.gov
NCT04616313Novel Pulmonary Imaging of Lung Structure and Function in E-cigarette SmokersBackgroundClinicalTrials.gov
NCT04711057CENTR(AR): Lungs MovingBackgroundClinicalTrials.gov
NCT04961060Drivers of Eosinophilic COPD ExacerbationsBackgroundClinicalTrials.gov
NCT05114434Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)ResultsClinicalTrials.gov
NCT05708443Effect of Combined Endurance Training on ADL and Walking in COPD PatientsBackgroundClinicalTrials.gov

See all 29 trialsDownload CSV of trials

Cited by1,662

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,534 citations.

PMIDTitleJournalYearIn PapersSource
42985238Case Finding for COPD in Nottingham and District (C FIND COPD). A Pilot Study of Uptake, Acceptability and Diagnostic Yield in a One-Stop Assessment Following Lung Cancer Screening.Int J Chron Obstruct Pulmon Dis2026https://conductscience.org/library/papers/42985238PubMed
42971626Predicting the persistence of Long COVID 36 months after hospitalisation: a prospective Ukrainian cohort study.BMJ Open2026https://conductscience.org/library/papers/42971626PubMed
42914145Tiotropium and clinically important deterioration in mild-to-moderate chronic obstructive pulmonary disease: a post hoc win ratio analysis of the Tie-COPD study.BMJ Open Respir Res2026https://conductscience.org/library/papers/42914145PubMed
42907865Repeatability and replicability of the Respiratory Symptom Experience Scale (RSES): internal and external validation of smoking-status differences in respiratory symptoms.Health Qual Life Outcomes2026https://conductscience.org/library/papers/42907865PubMed
42899053Effect of l-menthol on breathlessness and exercise endurance in COPD: a randomised crossover trial.ERJ Open Res2026https://conductscience.org/library/papers/42899053PubMed
42898520Latent classes and symptom network analysis of kinesiophobia in older adult patients with chronic obstructive pulmonary disease.Front Med (Lausanne)2026https://conductscience.org/library/papers/42898520PubMed
42882316Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden.Diagnostics (Basel)2026https://conductscience.org/library/papers/42882316PubMed
42882183Changes in Symptoms and Lung Function During Three Months of Individually Tailored Inhaled Therapy in Chronic Obstructive Pulmonary Disease: A Prospective Observational Cohort Study.J Clin Med2026https://conductscience.org/library/papers/42882183PubMed
42881582Changes in Physical Activity and Psychological Status in Patients with COPD Between Pre- and Post-COVID-19 Assessments: A Pilot Observational Longitudinal Cohort Study.Healthcare (Basel)2026https://conductscience.org/library/papers/42881582PubMed
42865803
Symptoms improvement and lung function benefits of fixed triple therapy with beclomethasone/formoterol/glycopyrronium inhalation powder in patients with moderate-to-severe COPD: outcomes of the Bulgarian arm of the RESPONSE study.
J Thorac Dis2026https://conductscience.org/library/papers/42865803PubMed
42856556Prevalence of anxiety and depression and diagnostic utility of the CAT scale in spirometry-confirmed COPD patients: Findings from the Chinese Population Health and Multimorbidities Study.Chin Med J Pulm Crit Care Med2026https://conductscience.org/library/papers/42856556PubMed
42831112A serum cytokine-derived integrated inflammatory profile score (IIPS) links systemic inflammation to symptom burden and severity in COPD.PeerJ2026https://conductscience.org/library/papers/42831112PubMed
42826262Cross-cultural adaptation and psychometric validation of the Arabic Leicester Cough Questionnaire in patients with chronic cough: A cross-sectional study.Medicine (Baltimore)2026https://conductscience.org/library/papers/42826262PubMed
42780717Chronic Obstructive Pulmonary Disease With Severe Airflow Limitation and Chronic Antitussive Use: Challenges in Diagnosis, Treatment Adherence, and Inhaler Technique: A Case Report.Cureus2026https://conductscience.org/library/papers/42780717PubMed
42776698COPD Assessment Test Variability as a Predictor of Exacerbations in Patients with COPD: A Prospective Study Using Virtual Assistant Monitoring.Adv Respir Med2026https://conductscience.org/library/papers/42776698PubMed
42775341Five-year changes in generic and disease-specific patient-reported outcome measures in stable COPD: a real-world cohort study.Patient Relat Outcome Meas2026https://conductscience.org/library/papers/42775341PubMed
42761771Insights into the Follow-Up of Patients with COPD in Daily Practice: Results from a Spanish Delphi Consensus ("The SEGUIPOC Study").Int J Chron Obstruct Pulmon Dis2026https://conductscience.org/library/papers/42761771PubMed
42757587Prevalence and impact of insomnia in patients with chronic obstructive pulmonary disease.Chron Respir Dis2026https://conductscience.org/library/papers/42757587PubMed
42743080Emphysema Treatment Gap and Gender Differences in a Lung Cancer Screening Cohort.Respiration2026https://conductscience.org/library/papers/42743080PubMed
42741596The Questionnaire for O2 Therapy Evaluation (QuOTE): a simple O2 therapy assessment.ERJ Open Res2026https://conductscience.org/library/papers/42741596PubMed

See all 1,662 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19720809

GET https://conductscience.org/api/papers/v1/19720809/trials?page=2